SUMOylation 2/3 Affinity Beads

SUMO-2/3 Antibody Mouse Monoclonal (20 assays) (Agarose bead conjugate)
$0.00
SKU
ASM24-Beads

As part of the Signal-Seeker™ product line, SUMOylation 2/3 affinity beads have been optimized in order to detect endogenous levels of SUMO 2/3 modified proteins, which often represent <1% of the target protein. SUMOylation 2/3 affinity beads comprise an anti-SUMO-2/3 antibody (Clone 11G2) that has been chemically conjugated to Protein G beads. Validation studies done in Hela cells have shown that these beads can immunoprecipitate a wide range of SUMO 2/3 modified proteins without detectable leaching of either heavy or light chains in an IP assay. A comprehensive Signal-Seeker™ SUMOylation 2/3 Detection Kit is also available (BK162) and is recommended for first time users.

Validation Data: SUMOylation 2/3 Affinity Beads White Paper

Each lot of affinity-bead is quality controlled  to provide high batch to batch consistency, see COA documents.

Validated Applications

Immunoprecipitation using the Signal-Seeker™ SUMOylation 2/3 Detection Kit

Denatured cell lysates were prepared as previously reported1 from HeLa cells ("HS43": Heat Shock treated 42°C  for 10 min, and "CT37": untreated) and HeLa siRNA SUMO knockdown ("KDS2"). 1mg of lysate was used for the immunoprecipitation (IP) of SUMOylated 2/3 proteins. Western blots of immunoprecipitated proteins were developed using anti-SUMO-2/3 antibody (Cytoskeleton cat# ASM23) (A) or anti-Ubc9 antibody (B). The level of SUMO-2/3 conjugates in heat shock treated cells is higher than control, and shRNA SUMO-2 knock-down reduced the level of SUMOylated 2/3 modified proteins. Chemical conjugation of SUMO-2/3 antibody (11G2) to the affinity bead matrix prevents heavy and light chain leaching. Unconjugated free SUMO is also captured by the SUMO-2/3 affinity beads.

(B) Unmodified Ubc9 is visible near 18kDa. High molecular-weight band indicates that Ubc9 is SUMOylated by a single SUMO-2/3 protein. Ubc9 has previously been reported to be a target for SUMOylation1,2

1. Barysch S. et al. 2014. Identification and analysis of endogenous SUMO1 and SUMO2/3 targets in mammalian cells and tissues using monoclonal antibodies. Nat Protoc. 9(4):896-909

2. Becker J. et al. 2013. Detecting endogenous SUMO targets in mammalian cells and tissues. Nature Struc. & Mol. Biol. 20, 525-531.

asm24-beads_1

Amount:
Each package contains enough SUMOylation 2/3 beads for 20 reactions.

 

For more information contact:  signalseeker@cytoskeleton.com

Associated Products:

Signal-Seeker™ SUMOylation 2/3 Detection Kit (Cat. # BK162)

Signal-Seeker™ Ubiquitination Detection Kit (Cat. # BK161)

Signal-Seeker™ Phosphotyrosine Detection Kit (Cat. # BK160)

Signal-Seeker™: BlastR™ Rapid Lysate Prep Kit (Cat. # BLR01)

Signal-Seeker™: PTMtrue™ SUMOylation 2/3 Antibody (Cat.# ASM23)

For product Datasheets and MSDSs please click on the PDF links below.

Click on the pdf icon below to download the manual

Certificate of Analysis:  Lot 021

If you have any questions concerning this product, please contact our Technical Service department at tservice@cytoskeleton.com

AuthorTitleJournalYearArticle Link
Waters, Emily et al.The SUMO protease SENP3 regulates mitochondrial autophagy mediated by Fis1EMBO reports2022
Zhou, Liwen et al.SUMOylation stabilizes hSSB1 and enhances the recruitment of NBS1 to DNA damage sitesSignal Transduction and Targeted Therapy2020
Horita, Henrick et al.Utilizing a comprehensive immunoprecipitation enrichment system to identify an endogenous post-translational modification profile for target proteinsJournal of Visualized Experiments2018
Horita, Henrick et al.Utilizing optimized tools to investigate PTM crosstalk: Identifying potential PTM crosstalk of acetylated mitochondrial proteinsProteomes2018
Horita, Henrick et al.A simple toolset to identify endogenous post-translational modifications for a target protein: A snapshot of the EGFR signaling pathwayBioscience Reports2017
Horita, Henrick et al.Identifying Regulatory Posttranslational Modifications of PD-L1: A Focus on MonoubiquitinatonNeoplasia (United States)2017

Visit our Signal-Seeker™ Tech Tips and FAQs page for technical tips and frequently asked questions regarding this and other Signal-Seeker™ products click here

 

If you have any questions concerning this product, please contact our Technical Service department at tservice@cytoskeleton.com